- Display 30 Products per page
Published: September 4, 2014 | Price: $4,200.00 – $8,400.00
Proteomics Markets for Clinical IVD Applications and Research Applications Kalorama Information report Proteomics Markets for Research and IVD Applications contains market estimates, forecasts and competitive analysis of this important area. Proteomics is the science of proteins, including the study of the function and form proteins. This includes the study of how and why proteins are expressed and how they interact with each other. Proteomics is a large field that has focused on research markets but has applications in therapeutics and...Published: September 4, 2014 | Price: $995.00 – $1,990.00
miRNA Research and Diagnostics Markets This report, miRNA Research and Diagnostic Markets, focuses on the test product potential of microRNA. These pieces of RNA are seen as important regulators of gene expression; including growth, form, differentiation, and apoptosis. They serve myriad functions as regulator molecules in post-transcriptional gene silencing. As the study details, a wide range of companies, both small biotechs and big pharmaceutical companies are committed to miRNA diagnostics. As part of its coverage of this topic, this report...Published: May 20, 2014 | Price: $995.00 – $1,990.00
Recent Biotech Funding, Deals and Partnerships Nearly one out of every 8 dollars invested in companies are invested in biotech. Biotech investment has increased significantly in the past few years, and 2013 saw a notable spike. In the last few years, this has resulted in a complex series of deals and transactions, ranging from complete buyouts, to licensing transactions, to a variety of collaborative arrangements. In addition to this influx of corporate capital, biotechnology companies have seen a significant influx...Published: April 29, 2014 | Price: $1,995.00 – $3,990.00
For capacity, accuracy, and specificity of analysis, the use of mass spectrometry in clinical diagnostics and clinical research has grown dramatically in recent years. This Kalorama Information report, Mass Spectrometry for Clinical Applications: Market Analysis and End User Survey, looks at the growth of Mass Spec systems being used in diagnostics and other clinical applications this year. A Detailed Examination of the Market Opportunity for MS in Clinical Applications Prior to the explosion in the last several years, GC-MS, LC-MS,...Published: January 23, 2014 | Price: $995.00 – $1,990.00
Next-Generation Sequencing in Latin America This report is an examination of the use of DNA sequencing systems in the Latin American region, based on a survey conducted in Fall 2013 by VA Consultadoros. The survey centered on instrumentation, with a goal of providing a complete count of next-generation sequencing (NGS) systems sold to customers in the major countries of Latin American. For the healthcare industry, Latin America is a focus. The region went through its highest economic growth period in...Published: October 16, 2013 | Price: $3,995.00 – $7,990.00
The effectiveness of biomarkers has made them essential to medicine, with successful products on the market and many products in development. This Kalorama Information report focuses on both the clinical biomarkers and research biomarkers in medicine. Biomarkers are physiologic, genetic or biochemical parameters that provide insight into understanding disease processes and ways that medicines can work to counteract the disease. With them, diseases are detected earlier, more effective treatments can be delivered, drug reactions reduced. An example is creatine kinase,...Published: August 15, 2013 | Price: $3,995.00 – $7,990.00
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Circulating tumor cells (CTCs) are believed to detach from primary or secondary tumors and enter the bloodstream, traveling to distant organs and forming new tumors. These cells that leave the primary tumor are able to colonize distant organs in the body and initiate the process of metastasis; however, their biology is still not entirely elucidated. Circulating tumor cells have tremendous utility in cancer research, aiding scientists in deciphering...Published: July 1, 2013 | Price: $1,500.00 – $3,000.00
Next Generation Sequencing Trends (Clinical Applications, Systems Used, Accreditation Status, Regulated Patient Sample Handling and Other Trends) Next-generation sequencing is discussed frequently as a key to clinical diagnostics in the future. This report looks at the status of NGS today, and seeks to provide insights on the “on-the-ground” status of clinical sequencing. In the course of doing this, the report seeks to answer the following questions: What is the status of clinical applications for Next Gen in laboratories currently? What...Published: June 7, 2013 | Price: $995.00 – $2,000.00
Computer diagnostics could offer opportunity for clinical laboratory professionals to add value to clinicians in diagnosing diseases. IT companies in collaboration with test vendors are developing computer software that complements the skills of human test interpretation. This report, Bioinformatics in IVD Testing looks at the various IVD market segments where bionformatics is expected to have the most impact. Bioinformatics-based testing has made a huge contribution to cancer diagnosis and therapy management. In infectious disease diagnostics it allows the detection of...Published: August 10, 2012 | Price: $995.00 – $1,990.00
Epigenetics (“Epi”; “over “ or “above” genetics) is recognized as those systems that control the expression of DNA-coded genes, but do not reside in the base pair sequences of the DNA. Rather, these control mechanisms are based on factors or molecules that bind to specific regions of the DNA (the genome), affecting gene expression. The three most important, and best understood mechanisms, are: Methylation, Histone Modulation and Micro RNA (or miRNA) Regulation This report an assessment of commercial outlook for...Published: March 1, 2012 | Price: $3,500.00 – $7,590.00
In this market research report, Kalorama Information defines the current opportunity and a realistic future potential for personalized medicine in clinical testing. In addition to analysis of tests currently on the market and in development, the report profiles key competitors and discusses trends that are important for understanding this much-discussed growth area of the diagnostic industry. The concept of 'Personalized Medicine', as seen by Kalorama clinical diagnostics industry analyst Shara Rosen, is currently somewhere between dream and road to reality....Published: January 1, 2012 | Price: $1,995.00 – $3,990.00
There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies. Stem cells also have value as a research tool, as their in vitro study would allow scientists to learn more about the function of various organs and the development of particular diseases; stem cells may also eventually permit drug developers to test emerging therapies on diseased cells....Published: November 1, 2011 | Price: $150.00 – $300.00
DNA Microarrays are utilized heavily by research labs for a number of tasks such as gene profiling, RNA detection and SNP analysis. But as Kalorama Information's DNA Market Trends report indicates, the market for these systems is about to experience change. The report authored by Kalorama Information biotech analyst Justin Saeks, is the result of surveys carried out with microarray labs to determine the current state of the microarray market and attempt to predict the future direction of the technologies....Published: October 15, 2011 | Price: $150.00 – $300.00
Several cell culture-derived biopharmaceutical drugs were launched in the US and European markets in 2010. Biopharmaceuticals (recombinant proteins, monoclonal antibody and nucleic acid-based products) represent the fastest growing sector in the pharmaceutical industry. Driving the extraordinary interest in biopharmaceuticals is the ability of these large proteins to target diseases in a very specific manner, thus maximizing efficacy while minimizing side effects. Growth in the development and production of biopharmaceuticals is the most significant driver of the cell culture market. Biological...Published: May 1, 2011 | Price: $150.00 – $300.00
The future of the pharmaceutical market will be determined by biologics - drugs produced by natural organisms or recombinant techniques consisting of proteins and other products derived from living organisms for the treatment or management of diseases or injuries. What are the products that lead the market now and what can we expect to see in the coming years? Find out in Kalorama Information's report, What's Next in Biologics?, which represents our latest research into the market for non-vaccine biological...Published: January 1, 2011 | Price: $150.00 – $300.00
Sample preparation and library preparation are important steps in the DNA sequencing process with specialized products and companies. Based on a survey of labs worldwide conducted by Kalorama's biotech analyst Justin Saeks, this report provides detailed information on the current state of DNA sequencing sample preparation and library preparation for next-generation systems, as well as sample preparation, cycle sequencing and sequencing reaction cleanup with capillary systems. The report's perspective is demand-side, focusing on what labs are doing today. The information...Published: September 1, 2010 | Price: $1,750.00 – $7,500.00
This Kalorama Information report, Hernia Repair Device Markets and Procedures provides global market sizes and forecasts, trends and competitive activity in this dynamic medical device segment. The development of prosthetic materials ushered in the current era of hernia surgery, allowing a tension-free repair to be performed even for the largest defects and the most difficult procedures. During the past decade, medicine has witnessed a revolutionary change in prosthetic biomaterials for application in hernia repair. Composite mesh with absorbable and non-absorbable...Published: April 1, 2010 | Price: $2,995.00 – $5,990.00
This report combines two of Kalorama's latest research volumes DNA Sequencing and SNP Genotyping and Analysis Markets into one package, and includes a preface on the complementary/competitive use of SNP Analysis and whole-genome sequencing on topics and the impact of the results of GWAS on the market.Published: February 1, 2010 | Price: $1,995.00 – $4,000.00
Because SNPs are the most common type of genetic variation between human beings, these specific single base pair mutations can be ideal for the task of hunting for correlations between genotype and behavior or quality exhibited by a living organism. For this reason, SNP analysis represents one of many possible pathways to personalzied medicine. The use of SNP analysis has spread into numerous areas in recent years. But diagnostics and pharmacogenomics are the most promising applications, and Kalorama has followed...Published: August 1, 2009 | Price: $3,800.00 – $7,600.00
Since the last edition of Kalorama Information's DNA Sequencing Equipment and Services report, the market has been changing in unpredictable ways as second-generation sequencers are being incrementally introduced and upgraded. On the surface, the situation has become somewhat linear and predictable, but as Kalorama Information biotech analyst Justin Saeks explains, it is actually a unique and relatively volatile situation that is not seen often with life science tools markets. Third-generation systems have the potential to completely change the market, or...Published: May 1, 2009 | Price: $995.00 – $7,990.00
Worldwide cancer affects more than 10 million people each year. This number is expected to increase by 2.4% by 2020 to 14 million each year. Worldwide approximately 22 million people are living with cancer and nearly 7 million people die. The most common cancers affecting the world include lung, breast, colon/rectum, stomach, liver, prostate, cervical, esophageal, and bladder. This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics - focuses on several segments for cancer treatment. The...Published: May 1, 2009 | Price: $2,995.00 – $7,990.00
Cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. As the biopharmaceutical market grows, so should interest in the cell culture products market. Biopharmaceutical products are developed from large, complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. As growing cells for biopharmaceutical production is slow, expensive and complicated, optimizing cell culture development is of paramount concern to companies developing biopharmaceuticals. This report, Cell Culture represents the second time that Kalorama...Published: April 1, 2009 | Price: $995.00 – $7,000.00
Pharmacodiagnostics are considered the pathway to what has been termed "personalized medicine," the use of molecular analysis to achieve optimum medical outcomes in the management of a patient’s disease or predisposition to disease. As such, personalized medicine promises to bring about a new standard of healthcare, with the possiblity to increase profits, speed clinical trials, achieve better clinical results and satisfy patients. But how can companies earn revenue in this undertaking? What are the likely challenges for pharma companies and...Published: March 1, 2009 | Price: $1,995.00 – $3,990.00
The liquid chromatography (LC) market has been relatively mature for quite a while, with a slow evolution of products and applications over the last few decades. High performance liquid chromatography (HPLC) has used essentially the same types of components since the 1980s. However, the market has seen an extraordinary amount of technological change in the last few years as companies have continued to introduce new systems performing fast LC and ultra HPLC (UHPLC). This report, Liquid Chromatography Markets,, represents Kalorama's...Published: February 1, 2009 | Price: $995.00 – $5,000.00
Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. Congress has also indicated a desire to move forward with stem cell research. The momentum in two branches of American government, along with scientific developments and the competition of world markets presages good market conditions for stem cell research. With their ability to differentiate and become an ongoing source of cells...Published: December 1, 2008 | Price: $995.00 – $1,990.00
Biophotonics describes the use of photonics in biomedical applications. There are several key areas that are associated with biophotonics. All of these center on microscopy and related technology. The reason that this is so is that biophotonics look at biological functions at the cellular level, or even smaller. The only way that these processes can be observed is via one or another form of microscopy. Among the different types of microscopy and associated technologies essential to the applications of biophotonics...Published: December 1, 2008 | Price: $995.00 – $1,990.00
The substances utilized for what is commonly referred to as 'protein therapeutics' have one thing in common --- they are all composed primarily of á-amino acids; and these á-amino acids are linked together by a distinct chemical bond known as a “peptide” bond. Used in a variety of areas of medicine, they are among the most interesting pharmaceutical markets. Above-Average Growth Rates What makes protein therapeutics interesting? The market for protein-based therapeutics is one that is significant in its size...Published: November 1, 2008 | Price: $4,995.00 – $14,995.00
Genetic Technology is one of the closest-watched areas in healthcare and in the past two years Kalorama Information has published major studies on different aspects of this market. This Kalorama Information Bundle consists of four major reports in biotech equipment: DNA Sequencing Equipment Markets: Markets, Forecasts, Sequencer Product Reviews and Company Profiles SNP Genotyping Markets: Single base pair mutations that occur at a specific site in the DNA sequence, the most common type of genetic variation between human beings. Because...Published: June 1, 2008 | Price: $1,995.00 – $7,990.00
SNPs (single nucleotide polymorphisms), single base pair mutations that occur at a specific site in the DNA sequence, are the most common type of genetic variation between human beings. Because they are responsible for over 80% of the variation between two individuals, SNPs are ideal for the task of hunting for correlations between genotype and behavior or quality exhibited by a living organism. The use of SNP analysis has spread into numerous areas in recent years. But diagnostics and pharmacogenomics...Published: March 1, 2008 | Price: $995.00 – $7,800.00
With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells. For market-watchers in the pharmaceutical industry, the question is what potential they have and where they could take the market. Kalorama Information has tackled that question in Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug...